Nymox Corporation
Pharmaceuticals, 230 W Passaic St, Maywood, New Jersey, 07607, United States, 11-50 Employees
Phone Number: +18*********
Who is NYMOX CORPORATION
Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia ...
Read More
-
Headquarters: 230 W Passaic St, Maywood, New Jersey, 07607, United States
-
Date Founded: 1995
-
Employees: 11-50
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 3841
|
NAICS Code: 339112 |
Show More
Does something look wrong? Fix it. | View contact records from NYMOX CORPORATION
Nymox Corporation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nymox Corporation
Answer: Nymox Corporation's headquarters are located at 230 W Passaic St, Maywood, New Jersey, 07607, United States
Answer: Nymox Corporation's phone number is +18*********
Answer: Nymox Corporation's official website is https://nymox.com
Answer: Nymox Corporation's revenue is Under $1 Million
Answer: Nymox Corporation's SIC: 3841
Answer: Nymox Corporation's NAICS: 339112
Answer: Nymox Corporation has 11-50 employees
Answer: Nymox Corporation is in Pharmaceuticals
Answer: Nymox Corporation contact info: Phone number: +18********* Website: https://nymox.com
Answer: Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month